SCHEMBL6589317

SCHEMBL6589317

FC(F)(F)c1ccccc1C1=CCN(CCc2ccc3ccncc3c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.45
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
HRH3 Q9Y5N1 1/20 0.38
PARP1 P09874 3/20 0.38
TMEM97 Q5BJF2 1/20 0.37
SLC6A4 P31645 1/20 0.36
DRD2 P14416 2/20 0.36
DRD4 P21917 2/20 0.36
DRD3 P35462 2/20 0.36
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7667728 0.89 PPARG (0.49) SIGMAR1PPARGPPARAHRH3PARP1
SCHEMBL6592540 0.84 SIGMAR1 (0.58) SIGMAR1PARP1DRD2DRD4DRD3
SCHEMBL6587088 0.83 SIGMAR1 (0.52) SIGMAR1PPARGPPARAPARP1DRD2
Ssr-150106 SCHEMBL29393331 0.82 SIGMAR1 (0.48) SIGMAR1PPARGPPARAPARP1DRD2
SCHEMBL6586330 0.82 HTR1A (0.52) SIGMAR1HRH3PARP1DRD2DRD4
Ssr-150106 SCHEMBL1385047 0.82 SIGMAR1 (0.48) SIGMAR1PPARGPPARAPARP1DRD2
SCHEMBL27476786 0.81 SIGMAR1 (0.39) SIGMAR1HRH3PARP1SLC6A4DRD2
SCHEMBL6589537 0.78 SIGMAR1 (0.51) SIGMAR1PARP1DRD2DRD4DRD3
Hydrochloric Acid SCHEMBL4587751 0.78 PPARG (0.51) SIGMAR1PPARGPPARAPARP1DRD2
SCHEMBL4589104 0.78 PPARG (0.51) SIGMAR1PPARGPPARAPARP1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226137-B8 PHENYL- AND PYRIDYL-TETRAHYDRO-PYRIDINES HAVING TNF INHIBITING ACTIVITY SANOFI AVENTIS (FR) 2004-12-15 EP disclosed
EP-1226137-B1 PHENYL- AND PYRIDYL-TETRAHYDRO-PYRIDINES HAVING TNF INHIBITING ACTIVITY SANOFI SYNTHELABO (FR) 2004-07-21 EP disclosed
US-6509351-B1 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation SANOFI-SYNTELABO (FR) 2003-01-21 US disclosed
EP-1226137-A1 PHENYL- AND PYRIDYL-TETRAHYDRO-PYRIDINES HAVING TNF INHIBITING ACTIVITY SANOFI-SYNTHELABO (FR) 2002-07-31 EP disclosed
WO-2001029026-A1 PHENYL- AND PYRIDYL-TETRAHYDRO-PYRIDINES HAVING TNF INHIBITING ACTIVITY SANOFI-SYNTHELABO (FR) 2001-04-26 WO disclosed